INBS Stock Price, Chart, Stats & News

Intelligent Bio Solutions Inc.
Save
1.34M
Market cap
–
Current P/E
–
Forward P/E
INBS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 29.87% |
Operating margin | -314.64% |
Pretax margin | -316.14% |
Net margin | -315.35% |
Effective tax rate | -0.11% |
ROA | -63.98% |
ROE | -197.93% |
D/E | 0.31x |
Interest coverage ratio | -132.30x |
INBS valuation
P/E | – |
P/S | 0.58x |
P/B | 0.28x |
P/CF | -0.33x |
P/FCF | -0.21x |
P/OCF | -0.33x |
PEG | -0.02x |
EV multiple | 0.06x |
About
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods.
Similar securities
Based on sector and market capitalization
Report issue











